ACRES Commercial Realty (ACR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
GAAP net income allocable to common shares was $2.8 million ($0.36 per diluted share) for Q3 2024, including a $2.8M gain from real estate conversion.
Loan portfolio decreased by $134.4 million in Q3 2024, with no new CRE loan originations and a focus on monetizing real estate assets and recycling capital into performing loans.
Student housing near Florida State University opened at 95% occupancy and is being marketed for sale.
Multifamily loans comprised 79–79.4% of the portfolio at September 30, 2024.
No common share distributions paid in 2024; focus remains on liquidity and book value growth.
Financial highlights
Book value per share increased to $27.92 at September 30, 2024, up from $27.20 in Q2 and $25.07 in Q3 2023.
Net interest income for Q3 2024 was $10.5 million; EAD was $0.24 per share, down from $0.51 in Q2.
Total assets were $2.0 billion at September 30, 2024; CRE whole loans at par totaled $1.6 billion across 56 loans.
Operating expenses for Q3 2024 were $17.1 million, up 4% year-over-year.
Weighted average loan-to-value (LTV) of the CRE loan portfolio was 78%.
Outlook and guidance
Management expects to complete most asset monetizations over the next two quarters, with book value per share projected to remain flat or improve.
Capital from asset sales will be redeployed into the loan book, with a focus on growing earnings and restoring a market-based dividend over the next 12 months.
Board expects to establish a plan for resuming common share distributions as earnings stabilize.
Manager remains focused on EAD growth and share repurchases to drive shareholder value.
Focus remains on prudent liquidity management and selective deployment of capital into new whole loan originations at attractive yields.
Latest events from ACRES Commercial Realty
- Q2 2026 net loss of $12.5M driven by merger costs; CRE loan book at $2.1B, internalization closing soon.ACR
Q2 2026 - All proposals, including director elections and merger share issuance, were approved by majority vote.ACR
AGM 2026 - Internalization Merger and new equity plan proposed to enhance governance and align interests.ACR
Proxy filing - Key votes include director elections, merger internalization, and new equity incentives.ACR
Proxy filing - Stockholders to vote on internalization merger, new equity plan, and key governance proposals.ACR
Proxy filing - Q1 2026 featured a $3.3M real estate gain, $1B securitization, and a merger/internalization.ACR
Q1 2026 - Q4 2025 net loss of $3M, $571M in new loans, book value up, and $1B CRE CLO closed.ACR
Q4 2025 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 2024 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 2025